Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.

14 May 2012

Analysis stresses importance of multidisciplinary approach to cancer in the elderly

New research showing that almost half of 13,000 patients with head and neck cancers had other health-related problems at the same time is one of the presentations in a special session at the 31st conference of the European Society for Radiotherapy and Oncology (ESTRO 31) today.

14 May 2012

Medication nonadherence linked to unnecessary cardiovascular hospitalizations in older patients

Older patients with high cholesterol or high blood pressure are at particular risk for unnecessary hospitalizations if they don't follow doctor's orders on taking their medications, according to new research from Express Scripts presented this week.

14 May 2012

Workout routine tips from NewYork-Presbyterian Hospital/CUMC

The summer is a great season for getting in shape. Whether by playing a sport, doing an aerobic exercise routine, or just returning to that familiar running path — this is the time for activity.

14 May 2012

CRT-D cost-effective treatment for mildly symptomatic heart failure patients

Medtronic, Inc. today announced findings from an economic analysis of the landmark RAFT (Resynchronization / Defibrillation in Ambulatory Heart Failure Trial) trial demonstrating that cardiac resynchronization therapy with defibrillation (CRT-D) is a cost-effective treatment for mildly symptomatic heart failure patients.

14 May 2012

Mylan introduces Atorvastatin Calcium in France, Belgium, UK, Ireland and the Netherlands

Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland.

11 May 2012

Positive results from Cytochroma CTAP101 Phase 2b clinical trial for CKD

Cytochroma today announced positive clinical trial results for its lead product, CTAP101 Capsules. In a recently completed Phase 2b trial, CTAP101 Capsules effectively and safely lowered elevated plasma intact parathyroid hormone (iPTH) in patients with Stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

11 May 2012

Two types of stent systems are both effective in treating iliac artery disease

Two types of stent systems are both effective in treating patients who have severe forms of peripheral artery disease (PAD), according to results of the MOBILITY trial presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions.

11 May 2012

Ixmyelocel-T shows promise against progressive heart failure

An investigational therapy derived from a patient's own bone marrow stem cells improves heart function in some patients with progressive heart failure due to dilated cardiomyopathy (DCM), according to the results of a Phase 2a study presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions.

11 May 2012

Preclinical evidence demonstrates link between psoriasis and cardiovascular disease

The link between psoriasis and cardiovascular events has been observed for years, however the mechanics were unknown. For the first time, Case Western Reserve University School of Medicine researchers have discovered preclinical evidence demonstrating that the inflammatory skin disease leads to cardiovascular disease. Further, the research demonstrated that aggressive reversal of psoriasis reduces the cardiovascular risk as well.

11 May 2012

Robotic system can safely assist interventional cardiologists in performing PCI

A robotic system can safely assist interventional cardiologists in performing percutaneous coronary interventions (PCI) while significantly reducing the physician's exposure to radiation and improving precision and control, according to results of the PRECISE study (CorPath Percutaneous Robotically-Enhance Coronary Intervention Study), presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions.

11 May 2012

New report provides detailed criteria for rational and timely use of cardiac catheterization

A new report issued today by the American College of Cardiology Foundation (ACCF) and the Society for Cardiovascular Angiography and Interventions (SCAI) in collaboration with a dozen other professional societies provides detailed criteria to help clinicians determine when cardiac catheterization is a reasonable option for the evaluation of patients for heart disease.

10 May 2012

Resverlogix completes RVX-208 Phase 2b trial on CVD

Resverlogix Corp. is pleased to announce that dosing in SUSTAIN, a Phase 2b clinical trial to assess lipid trends and safety of RVX-208, has been completed on schedule.

10 May 2012

Antidepressives reduce risk of suicides in schizophrenic patients

Antidepressive drugs reduce the mortality rate of schizophrenic patients, while treatment with bensodiazepines greatly increases it, especially as regards suicide. Giving several antipsychotics simultaneously, however, seems to have no effect at all. This according to a new study examining different drug combinations administered to patients with schizophrenia.

9 May 2012

Medtronic’s Valiant Captivia Stent Graft now available in seven countries

Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. is expanding availability of the Valiant Captivia Thoracic Stent Graft System in several countries, including China, Japan and the United States.

From Medtronic 9 May 2012

Researchers discover location and effect of abnormal heart proteins

University of Guelph researchers have found the location and effect of abnormal heart proteins that can cause cardiac failure, a discovery that points to potential new ways to treat the most costly health problem in the world.

9 May 2012

Call for cookery lessons in schools to reduce childhood obesity

Health professionals, charity leaders and celebrities, including Steven Gerrard and Jamie Oliver, are calling for cookery lessons to be introduced to schools for all children aged between 4 and 14 years old.

8 May 2012

'Good' cholesterol may not protect against coronary heart disease

A new study by Harvard School of Public Health (HSPH) researchers has found that a subclass of high-density lipoprotein (HDL) cholesterol, the so-called "good" cholesterol, may not protect against coronary heart disease (CHD) and in fact may be harmful.

8 May 2012

Long-term exposure to roadways linked with increased risk of death in patients with heart attack

Living close to a major highway poses a significant risk to heart attack survivors, reinforcing the need to isolate housing developments from heavy traffic areas, a Beth Israel Deaconess Medical Center study concludes.

8 May 2012

Flavan-3-ols, SoyLife can improve biomarkers of CVD risk in postmenopausal type 2 diabetic patients

A new, one-year, double-blind controlled clinical study shows that cacao-flavonoids and soy isoflavones can significantly improve biomarkers of CVD risk in postmenopausal women with type 2 diabetes.

5 May 2012

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

Analysis stresses importance of multidisciplinary approach to cancer in the elderly

Medication nonadherence linked to unnecessary cardiovascular hospitalizations in older patients

Workout routine tips from NewYork-Presbyterian Hospital/CUMC

CRT-D cost-effective treatment for mildly symptomatic heart failure patients

Mylan introduces Atorvastatin Calcium in France, Belgium, UK, Ireland and the Netherlands

Positive results from Cytochroma CTAP101 Phase 2b clinical trial for CKD

Two types of stent systems are both effective in treating iliac artery disease

Ixmyelocel-T shows promise against progressive heart failure

Preclinical evidence demonstrates link between psoriasis and cardiovascular disease

Robotic system can safely assist interventional cardiologists in performing PCI

New report provides detailed criteria for rational and timely use of cardiac catheterization

Resverlogix completes RVX-208 Phase 2b trial on CVD

Antidepressives reduce risk of suicides in schizophrenic patients

Medtronic’s Valiant Captivia Stent Graft now available in seven countries

Researchers discover location and effect of abnormal heart proteins

Call for cookery lessons in schools to reduce childhood obesity

'Good' cholesterol may not protect against coronary heart disease

Long-term exposure to roadways linked with increased risk of death in patients with heart attack

Flavan-3-ols, SoyLife can improve biomarkers of CVD risk in postmenopausal type 2 diabetic patients

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in